Literature DB >> 35693106

Comment on "Evaluation of antibiotic resistance of Helicobacter pylori bacteria obtained from gastric biopsy samples: A cohort study".

Kiarash Ghazvini1,2, Masoud Keikha1,2.   

Abstract

Entities:  

Year:  2022        PMID: 35693106      PMCID: PMC9178462          DOI: 10.1016/j.amsu.2022.103945

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


× No keyword cloud information.
Dear Editor Azadbakht et al., recently published an interesting study entitled “Evaluation of antibiotic resistance of Helicobacter pylori bacteria obtained from gastric biopsy samples: A cohort study” in the Journal of Annals of Medicine and Surgery [1]. Antibiotic resistance H. pylori infection is considered as one of the main challenge of treatment failure that cause to chronic persistent infection as well as increase the risk of gastric adenocarcinoma [2]. Thus, mass H. pylori eradication is recommended by American gastroenterology society to decline risk of gastric cancer [3,4]. In the subsequent section, we suggest some constructive points to enrich this study: Helicobacter pylori (H. pylori) should be stated with italic font throughout the manuscript. Routinely, the Etest (previously known as the Epsilometer test), Agar dilution, as well as molecular test e.g. PCR, PCR-RFLP, sequencing method was reliable methods for detection of antibiotic resistance in H. pylori infection [5]. However, the author was not mentioned; antibiotic resistance in H. pylori strains how was detected in this study? Invalidated methods for H. pylori antibiogram can refuse the validity of the current results as a risk bias. There are some unclear terms in methods, for example the sentence “Helicobacter pylori was achieved using cellular characteristics in hot staining”, we have not hot staining for detection of H. pylori infection; do you mean gram-staining? Taking together, better study design in relevant future investigations are need to validate the present findings as well as provide increased understanding about epidemiology of antibiotic resistance in H. pylori infection in such developing countries.

Ethical approval

Not applicable for this study.

Sources of funding

There is no fund for this manuscript.

Author contribution

Masoud Keikha contribute in conceptional, study design, review of the literatures, writing the draft and revision. Kiarash Ghazvini contribute in writing the draft and revision. All authors agree with publish in this journal.

Research registration unique identifying number (UIN)

Name of the registry: Not applicable. Unique Identifying number or registration ID: Not applicable. Hyperlink to your specific registration (must be publicly accessible and will be checked): Not applicable.

Guarantor

Not applicable for this study.

Declaration of competing interest

There is no conflict of interest.
  5 in total

1.  Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis.

Authors:  Mitsushige Sugimoto; Masaki Murata; Yoshio Yamaoka
Journal:  World J Gastroenterol       Date:  2020-04-21       Impact factor: 5.742

2.  Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology.

Authors:  C W Howden; R H Hunt
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

3.  Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis.

Authors:  Masoud Keikha; Parvin Askari; Kiarash Ghazvini; Mohsen Karbalaei
Journal:  J Glob Antimicrob Resist       Date:  2021-11-14       Impact factor: 4.349

4.  Evaluation of antibiotic resistance of Helicobacter pylori bacteria obtained from gastric biopsy samples: A cohort study.

Authors:  Saleh Azadbakht; Alireza Moayyedkazemi; Salehe Azadbakht; Siamak Alihoseini Fard; Setareh Soroush
Journal:  Ann Med Surg (Lond)       Date:  2022-05-18

5.  The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.

Authors:  Yi-Chia Lee; Tony Hsiu-Hsi Chen; Han-Mo Chiu; Chia-Tung Shun; Hung Chiang; Tzeng-Ying Liu; Ming-Shiang Wu; Jaw-Town Lin
Journal:  Gut       Date:  2012-06-14       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.